The Valley Desk

NCT02900716 · Interventional trial

Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas

Overall registry status Completed

Phase 1

Conditions B-Cell Lymphoma, Chronic Lymphocytic Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov